Characterization of the metabolism of eupalinolide A and B by carboxylesterase and cytochrome P450 in human liver microsomes
Frontiers in Pharmacology · 25.01.2023 · 14
DOI: 10.3389/fphar.2023.1093696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.01.2023. Verfasst von Yingzi Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology, School of Public Health, Peking University, Beijing, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Eupalinolide A (EA; Z-configuration) and eupalinolide B (EB; E-configuration) are bioactive cis-trans isomers isolated from Eupatorii Lindleyani Herba that exert anti-inflammatory and antitumor effects. Although one pharmacokinetic study found that the metabolic parameters of the isomers were different in rats, metabolic processes relevant to EA and EB remain largely unknown. Our preliminary findings revealed that EA and EB are rapidly hydrolyzed by carboxylesterase. Here, we investigated the metabolic stability and enzyme kinetics of carboxylesterase-mediated hydrolysis and cytochrome P450 (CYP)-mediated oxidation of EA and EB in human liver microsomes (HLMs). We also explored differences in the hydrolytic stability of EA and EB in human liver microsomes and rat liver microsomes (RLMs). Moreover, cytochrome P450 reaction phenotyping of the isomers was performed via in silico methods (i.e., using a quantitative structure-activity relationship model and molecular docking) and confirmed using human recombinant enzymes. The total normalized rate approach was considered to assess the relative contributions of five major cytochrome P450s to EA and EB metabolism. We found that EA and EB were eliminated rapidly, mainly by carboxylesterase-mediated hydrolysis, as compared with cytochrome P450-mediated oxidation. An inter-species difference was observed as well, with faster rates of EA and EB hydrolysis in rat liver microsomes. Furthermore, our findings confirmed EA and EB were metabolized by multiple cytochrome P450s, among which CYP3A4 played a particularly important role.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Toxicology, School of Public Health, Peking University, Beijing, China.
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
- Key Laboratory of State Administration of Traditional Chinese Medicine for Compatibility Toxicology, Beijing, China.
- Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, Y., Liu, X., Li, L., Zhang, T., Gao, Y., Zeng, K., & Wang, Q. (2023). Characterization of the metabolism of eupalinolide A and B by carboxylesterase and cytochrome P450 in human liver microsomes. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1093696
Vancouver
Li Y, Liu X, Li L, Zhang T, Gao Y, Zeng K, et al. Characterization of the metabolism of eupalinolide A and B by carboxylesterase and cytochrome P450 in human liver microsomes. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1093696
BibTeX
@article{Li2023,
author = {Li, Yingzi and Liu, Xiaoyan and Li, Ludi and Zhang, Tao and Gao, Yadong and Zeng, Kewu and Wang, Qi},
title = {Characterization of the metabolism of eupalinolide A and B by carboxylesterase and cytochrome P450 in human liver microsomes},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1093696}
}
EUVIMED